Amwill Health Care Limited announced the re-appointment of its Managing Directors, Mr. Tarun Gandhi and Mr. Anand Gandhi, for a further term of five years. The approval was secured through a special resolution passed by the Members at the 9th Annual General Meeting held on August 14, 2026. Their new terms commence on January 27, 2027, and will conclude on January 26, 2032, ensuring continued leadership and strategic direction for the company.
Leadership Continuity at Amwill Health Care
Amwill Health Care Limited has successfully secured the re-appointment of its key leadership figures. At the 9th Annual General Meeting (AGM) held on August 14, 2026, shareholders approved a special resolution to extend the tenure of Mr. Tarun Gandhi (DIN: 07854699) and Mr. Anand Gandhi (DIN: 07854706) as Managing Directors. This decision ensures a stable and experienced leadership team at the helm of the company.
Extended Tenures and New Terms
Both Mr. Tarun Gandhi and Mr. Anand Gandhi have been re-appointed for a consecutive term of five (5) years. Their new mandates will officially begin on January 27, 2027, and will extend until January 26, 2032. This re-appointment was made on the recommendations of the Nomination & Remuneration Committee and the Board of Directors, underscoring a unified strategic vision for the company’s future growth and operations.
Background and Experience
Mr. Tarun Gandhi, holding DIN 07854699, brings over a decade of experience in financial management, accounts management, and business development. He holds a bachelor’s degree in commerce with honors from Bangalore University. Mr. Anand Gandhi, DIN 07854706, is a seasoned professional with more than ten years of experience in brand placement, marketing, and sales within the dermatology segment of the pharmaceutical industry. He possesses bachelor’s and master’s degrees in pharmacy (pharmaceutics) with honors from Rajiv Gandhi University of Health Sciences.
Both individuals are deemed qualified to hold their respective offices and are not debarred by any SEBI order or other relevant authorities from holding directorial positions. The detailed terms of their re-appointment and remuneration will be as approved by the Members and outlined in the notice for the 9th AGM.
Source: BSE
